Alembic Pharma's Q3FY24 Quarter Results

Alembic Pharma’s revenues grew 8% YoY
  • 05 Feb 2024
  • Alembic Pharma reported 2% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter ended December (Q3FY24). On a year-on-year (YoY) basis, it witnessed a growth of 8%.
  • Its expenses for the quarter were down by 1% QoQ and up 8% YoY.
  • The net profit grew 32% QoQ and 48% YoY.
  • The earnings per share (EPS) of Alembic Pharma stood at 9.2 during Q3FY24.

Alembic Pharma’s Financial Statements for Q3FY24:

(Rs crores) Q3FY23 Q2FY24 Q3FY24 QoQ (%) YoY (%)
Total income
1,509
1,605
1,633
2%
8%
Total expenses
1,341
1,470
1,449
-1%
8%
Profit before tax
154
135
185
37%
19%
Tax
33
-2
4
-
-87%
Profit after tax
122
137
180
32%
48%
Earnings per share
6.2
7.0
9.2

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Open Demat Account
or Resume your Application
+91 -

personImage